Uniphar, a diversified healthcare services organisation, agreed to acquire BModesto Group, a Netherlands-headquartered healthcare services business, for €75m. "BModesto is a significant addition to the Group, strengthening our Product Access offering in Europe and beyond. The acquisition is another step in achieving our strategy of becoming a global leader in the ethical provision of access to medicines which remain unlicensed at the point of care. It also provides a further boost to our capabilities in the provision of Expanded Access Programs for innovative new medicines. The company's strategic location, sophisticated sourcing, regulatory capabilities and broad access to key end markets strengthens our evolving global service offering and will allow us to make a positive difference in the lives of more patients. We are delighted to welcome the highly talented BModesto team to the Group," Ger Rabbette, Uniphar CEO.